DDG-24729-64947
3 vaccinations
6 coded responses
34 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 790 / TX
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Moderna
-
2021-01-13
Registered in v-safe
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-09
Dose 2 — Moderna
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Balance disorder, Nervous system disorder — Feeling: Good · Muscle or body achesFree text: Slight neurological and balance problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Balance disorder, Nervous system disorder — Feeling: Good · Muscle or body achesFree text: Slight neurological and balance problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — day 7, dose 2MedDRA: Balance disorder, Nervous system disorder — Feeling: Good · Muscle or body achesFree text: Slight neurological and balance problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
-
2021-08-10
Survey response — 6 months, dose 2MedDRA: Balance disorder, Memory impairment, Mental impairment, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Mental acuity, balance problems, memory · Healthcare visit (other): Primary care physician in person office visitMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-10
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-19
-
2021-10-25
Dose 3 — Moderna
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
-
2021-11-08
Survey response — day 14, dose 3MedDRA: Rash — Feeling: GoodFree text: Reason unknown for skin rash in groin area first noticed after Moderna booster.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
-
2022-01-24
Survey response — 3 months, dose 3MedDRA: Dyspnoea, Office visit, Pulmonary function test decreased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shortness of breath. My pulmonologist said my lung function tests has greatly diminished in comparison to function test six months ago possibly caused by a blood clot. Test results aren't back to determine further testing such as MRI with contrastMedDRA releases: 2024-11 · check-in free text available
- 2022-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-09 | Moderna | |
| 3 | 2021-10-25 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Slight neurological and balance problems
Systemic reaction (other): Slight neurological and balance problems
Release 4 — day 7, dose 2
Systemic reaction (other): Slight neurological and balance problems
Release 9 — 6 months, dose 2
Symptoms: Mental acuity, balance problems, memory
Healthcare visit (other): Primary care physician in person office visit
Release 10 — day 14, dose 3
Symptoms: Reason unknown for skin rash in groin area first noticed after Moderna booster.
Release 11 — 3 months, dose 3
Symptoms: Shortness of breath. My pulmonologist said my lung function tests has greatly diminished in comparison to function test six months ago possibly caused by a blood clot. Test results aren't back to determine further testing such as MRI with contrast
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Balance disorder | ✓ | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Memory impairment | ✓ | · | ✓ |
| SD | Mental impairment | ✓ | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pulmonary function test decreased | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Balance disorder | ✓ | ✓ | ✓ |
| SRO | Nervous system disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release